Abstract:Background: To investigate the quantification of aneurysmal wall enhancement (AWE) in fusiform intracranial aneurysms (FIAs) and to compare AWE parameters based on different sections of FIAs in identifying aneurysm symptoms. Methods: Consecutive patients were prospectively recruited from February 2017 to November 2019. Aneurysm-related symptoms were defined as sentinel headache and oculomotor nerve palsy. All patients underwent high resolution magnetic resonance imaging (HR-MRI) protocol, including both pre and post-contrast imaging. CR stalk (signal intensity of FIAs' wall divided by pituitary infundibulum) was evaluated both in the cross-section (CR stalk−cross ) and the long-axis section (CR stalk−long ) of FIAs. Aneurysm characteristics include the maximal diameter of the cross-section ( D max ), the maximal length of the long-axis section ( L max ), location, type, and mural thrombus. The performance of parameters for differentiating symptomatic and asymptomatic FIAs was obtained and compared by a receiver operating characteristic (ROC) curve. Results: Forty-three FIAs were found in 43 patients. Eighteen (41.9%) patients who presented with aneurysmal symptoms were classified in the symptomatic group. In univariate analysis, male sex ( P = 0.133), age ( P = 0.013), FIAs type ( P = 0.167), mural thrombus ( P = 0.130), L max ( P = 0.066), CR stalk−cross ( P = 0.027), and CR stalk−long ( P = 0.055) tended to be associated with aneurysmal symptoms. In the cross-section model of multivariate analysis, male ( P = 0.038), age ( P = 0.018), and CR stalk−cross ( P = 0.048) were independently associated with aneurysmal symptoms. In the long-axis section model of multivariate analysis, male ( P = 0.040), age ( P = 0.010), CR stalk−long ( P = 0.046), and L max ( P = 0.019) were independently associated with aneurysmal symptoms. In the combination model of multivariate analysis, male ( P = 0.027), age ( P = 0.011), CR stalk−cross ( P = 0.030), and L max ( P = 0.020) were independently associated with aneurysmal symptoms. CR stalk−cross has the highest accuracy in predicting aneurysmal symptoms (AUC = 0.701). The combination of CR stalk−cross and L max exhibited the highest performance in discriminating symptomatic from asymptomatic FIAs (AUC = 0.780). Conclusion: Aneurysmal wall enhancement is associated with symptomatic FIAs. CR stalk−cross and L max were independent risk factors for aneurysmal symptoms. The combination of these two factors may improve the predictive performance of aneurysmal symptoms and may also help to stratify the instability of FIAs in future studies.

Statins may Decrease Aneurysm wall Enhancement of Unruptured Fusiform Intracranial Aneurysms: A high-resolution 3T MRI Study

Aneurysm wall enhancement, atherosclerotic proteins, and aneurysm size may be related in unruptured intracranial fusiform aneurysms

Effect of Statin Treatment on Vasospasm-Related Morbidity and Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis

Quantification of aneurysm wall enhancement in intracranial fusiform aneurysms and related predictors based on high-resolution magnetic resonance imaging: a validation study

Statin Treatment for Unruptured Intracranial Aneurysms Study: a Study Protocol for a Double-Blind, Placebo-Controlled Trial

Relationship Between Aneurysm Wall Enhancement and Conventional Risk Factors in Patients with Unruptured Intracranial Aneurysms: A Black-Blood MRI Study.

Aneurysmal Wall Enhancement and Hemodynamics: Pixel-Level Correlation Between Spatial Distribution

Morphological Parameters Related to Aneurysm Wall Enhancement in Patients with Multiple Intracranial Aneurysms

Comparisons between cross-section and long-axis-section in quantification of aneurysmal wall enhancement of fusiform intracranial aneurysms in identifying aneurysmal symptoms

A preliminary assessment of the intracranial aneurysm wall imaging with high-resolution magnetic resonance imaging

Application of High-Resolution MRI in Evaluating Statin Efficacy on Symptomatic Intracranial Atherosclerosis

Neutrophil-to-Lymphocyte Ratio Is Associated With Circumferential Wall Enhancement of Unruptured Intracranial Aneurysm

Irregular Pulsation on 4D-CTA and Quantitative Wall Enhancement on VW-MRI Are Associated with Symptoms of Unruptured Intracranial Aneurysms

Does it stable? Intracranial aneurysm wall enhancement might be the warning signals: a meta-analysis of observational studies

The value of systemic immune inflammation index, white blood cell to platelet ratio, and homocysteine in predicting the instability of small saccular intracranial aneurysms

Associations between haemodynamics and wall enhancement of intracranial aneurysm

Increased Wall Enhancement Extent Representing Higher Rupture Risk of Unruptured Intracranial Aneurysms.

Analysis of enhancement features of unruptured intracranial aneurysms based on high-resolution magnetic resonance vessel wall imaging

Analysis of Serum Cholesterol, Statins and Atherosclerotic Plaque in Ruptured and Unruptured Intracranial Aneurysm

Dimethyl fumarate treatment for unruptured intracranial aneurysms: a study protocol for a double-blind randomised controlled trial

Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials